Stroke / Neuro Critical Care
Comprehensive Stroke CareOpens new window | Adult Clinical Trials Main Page
Further protocol information can be found on the links below at ClinicalTrials.gov
Title: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Description: Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Investigator: Nobl Barazangi, MD
Eligibility: 18 years of age and older with the ability to randomize within 12 hours of symptom onset
Status: Active and open to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study POINT
Title: Expanding the Time Window for IV Thrombolysis with rt-PA in Acute Ischemic Stroke Patients Using Computed Tomography Perfusion Imaging: The PERFusion Use in Stroke Evaluation (PERFUSE) Study
Description: Patients with ischemic stroke who can be treated within six hours of symptom onset
Investigator: Nobl Barazangi, MD
Eligibility: Acute Ischemic Stroke (AIS) patients, ≥ 18 years old, who present up to 6 hours from time of onset of acute stroke symptoms
Status: Active and open to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study PERFUSE
Title: A Phase III Randomized Multicenter Clinical Trial of High-Dose Human Albumin Therapy for Neuroprotection in Acute Ischemic Stroke -- ALIAS
Description: Albumin in Acute Ischemic Stroke Trial (ALIAS)
Investigator: Nobl Barazangi, MD
Eligibility: Patients less than 84 years in age with acute ischemic stroke
Status: Active and open to enrollment
Contact: Jessica Redford, RN, 415-600-1781,
Email: RedforJ@cpmcri.org about Study ALIAS
- updated January 2012
Back to top